Showing results (211-220 of 300) with videos related to

Sort By:
Pageof 30
Drug Discovery Today|October 23, 2022
pH and its applications in targeted drug deliverySadikalmahdi Abdella, Fatima Abid, Souha H Youssef, et al.
Pharmaceutics|November 27, 2024
The Acid-Buffered Engineered Gel Promotes In Vitro Cutaneous Healing and Fights Resistant Bacteria in WoundsFatima Abid, Emmeline Virgo, Tahlia Louise Kennewell, et al.
American Journal of Obstetrics and Gynecology|September 13, 2012
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestationSteve N Caritis, Shringi Sharma, Raman Venkataramanan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 7, 2012
Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytesShringi Sharma, Ewa C S Ellis, Roberto Gramignoli, et al.
AIDS Patient Care and Stds|September 19, 2003
Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challengesSanjay Garg, Kaustubh R Tambwekar, Kavita Vermani, et al.
ACS Applied Materials & Interfaces|December 22, 2021
Polycationic Silver Nanoclusters Comprising Nanoreservoirs of Ag<sup>+</sup> Ions with High Antimicrobial and Antibiofilm ActivityHanif Haidari, Richard Bright, Zlatko Kopecki, et al.
International Journal of Pharmaceutics|June 11, 2024
Polymeric functionalization of mesoporous silica nanoparticles: Biomedical insightsAkhil Nair, Raghu Chandrashekhar H, Candace M Day, et al.
The New Zealand Medical Journal|March 27, 2007
Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective surveyTherése Kairuz, Srey Chhim, Fhazeel Hasan, et al.
British Journal of Clinical Pharmacology|September 17, 2021
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignanciesHelena Edlund, Núria Buil-Bruna, Karthick Vishwanathan, et al.
AIDS Patient Care and Stds|March 5, 2003
Development pharmaceutics of microbicide formulations. Part I: preformulation considerations and challengesSanjay Garg, Raghupathi Kandarapu, Kavita Vermani, et al.
Pageof 30